|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Botanical ingredients demand drives quality focus
|
|
Monday, 05 October, 2026, 08 : 00 AM [IST]
|
|
Anurag More, Mumbai
|
The market for botanical and nutraceutical ingredients is moving beyond conventional herbal powders. According to Pramod Chandra, Director, Star Bio Pharma Global Pvt Ltd, customers are increasingly seeking standardised, traceable ingredients designed for specific applications across nutraceuticals, functional foods, pharmaceuticals and wellness products.
“Demand for plant-based ingredients is shifting from generalised herbal powders to standardised and traceable products with clearly defined applications,” says Chandra. “Ingredients such as curcumin, piperine, ashwagandha and ginkgo biloba are finding growing use across multiple industries.”
This shift is also changing the expectations placed on ingredient suppliers. Buyers are demanding comprehensive documentation, stable quality, consistent potency and reliable batch-to-batch performance. For organised suppliers with robust quality systems, this trend is creating significant opportunities.
Caffeine anhydrous continues to be a versatile ingredient with applications across sports nutrition, energy drinks, functional beverages, nutraceuticals and pharmaceutical formulations.
Chandra believes the ingredient offers opportunities in both Indian and international markets, provided suppliers can meet increasingly stringent expectations around quality and compliance.
“Caffeine anhydrous can be used across sports nutrition, energy drinks, health products and pharmaceuticals,” he says. “The key is to provide consistent quality supported by valid specifications and complete documentation.”
As consumers continue to seek products that support energy, alertness and physical performance, demand for caffeine-based formulations is expected to remain strong. For ingredient suppliers, the ability to deliver dependable quality and regulatory support will be essential to capturing this demand.
Maintaining consistency, purity and potency across botanical ingredients remains one of the industry’s most significant challenges. Unlike synthetic ingredients, plant-based materials can vary considerably depending on their origin and production conditions.
Factors such as geographical location, agricultural practices, harvesting methods and post-harvest processing can all influence the composition and quality of herbal raw materials.
“The main challenge is the consistency of the materials used,” explains Chandra. “This can only be achieved through controlled sourcing, testing, standardisation and effective batch control.”
For botanical ingredient manufacturers, this requires close oversight of the entire value chain—from supplier qualification and raw-material testing to processing, standardisation, packaging and final release.
The traditional boundaries between pharmaceuticals, nutraceuticals, functional foods and wellness products are becoming increasingly interconnected. This convergence is encouraging manufacturers to develop ingredients that can meet the requirements of more than one product category.
Chandra says this is influencing Star Bio Pharma Global’s product strategy. “There is a growing need for ingredients that can be used across different categories while fulfilling all the necessary requirements,” he says.
The company’s approach is focused on specialised, high-quality ingredients that have demonstrated practical value in formulation and application. This includes products capable of supporting the technical, quality and documentation requirements of different customer segments.
As customers demand greater transparency, traceability has become a central component of ingredient quality management. For Star Bio Pharma Global, traceability is intended to provide visibility across the entire supply chain.
The company’s quality approach includes supplier evaluation, raw-material testing, batch-level quality control and oversight of processing and packaging operations.
“Traceability ensures total visibility along the entire supply chain,” says Chandra. “Our efforts are directed towards evaluating suppliers, testing raw materials, conducting batch quality control and managing processing operations effectively.”
This level of control is increasingly important as manufacturers and brands seek to demonstrate the identity, purity, origin and consistency of the ingredients used in their products.
Looking ahead, Star Bio Pharma Global expects continued growth in plant-based substances, functional additives, specialised phytochemicals, sports supplements and wellness-supporting ingredients.
The market is also moving towards more efficient and potent standardised extracts, as formulators seek to deliver targeted benefits in convenient and scientifically supported formats.
“We anticipate further growth in plant-based substances, functional additives, specialised phytochemicals, sports supplements and wellness-supporting components,” Chandra says. “The market is also shifting towards highly efficient standardised extracts.”
At the same time, customer expectations around clean-label and natural ingredients are becoming more sophisticated. Natural positioning alone is no longer sufficient. Buyers increasingly want evidence of responsible sourcing, purity, controlled processing, standardisation and reliable documentation.
“Customers are paying greater attention to the source, purity, processing and transparency of ingredients,” Chandra notes. “Natural positioning is no longer enough. Customers are looking for natural sources backed by standardisation, consistency, documentation and reliable quality.”
Indian ingredient manufacturers are well positioned to serve global demand, but they face the challenge of balancing quality, regulatory compliance, cost and supply reliability.
Different international markets have different expectations regarding technical documentation, regulatory compliance, product specifications and quality certifications. As a result, Indian suppliers must adopt a market-specific approach rather than relying solely on price competitiveness. “The main challenge is not to compete only on price, but also to build a reputation through consistent and reliable quality,” says Chandra.
Star Bio Pharma Global is focusing on strengthening relationships across Asian, African, European and Latin American markets. The company has identified interest in ingredients such as piperine from markets including Japan, Taiwan, Africa, Argentina and Europe. Its export strategy centres on building long-term customer relationships, understanding regional requirements and delivering dependable quality across markets.
Volatility in raw-material availability, pricing and international logistics has made supply-chain resilience a key priority for ingredient businesses.
Chandra believes that maintaining alternative sources and developing strong relationships with multiple suppliers are essential to reducing risk. Proactive planning is also required to manage inventory, seasonal variations and fluctuations in logistics.
“Ensuring a reliable supply chain requires alternative suppliers and good relationships with them through proactive planning,” he explains. “Effective stock planning is also important to prevent disruptions in customer deliveries caused by logistics fluctuations and seasonal variations.” This approach enables suppliers to respond more effectively to market changes while protecting continuity of supply for formulators and manufacturers.
In the B2B ingredients sector, long-term partnerships are becoming increasingly important. Customers require not only product availability but also consistent specifications, dependable delivery and technical understanding of their applications.
For Star Bio Pharma Global, the objective is to work closely with formulators, pharmaceutical companies, nutraceutical brands and food manufacturers to understand their specific requirements.
“Long-term relationships are crucial because customers demand consistency and reliability of supply,” says Chandra. “Our goal is to understand clients’ needs in terms of composition and application and become a reliable partner rather than simply a vendor.” This partnership-based approach can help ingredient suppliers support customers through product development, formulation optimisation and supply-chain planning.
Star Bio Pharma Global is also evaluating opportunities to expand beyond its existing portfolio of herbal extracts, nutraceutical ingredients, APIs and phytochemicals.
The company is exploring high-value herbal products, specialised phytochemicals, nutraceuticals and specialty ingredients. However, Chandra emphasises that expansion will remain focused on areas where the company can maintain high-quality standards and deliver meaningful value to B2B customers.
“Widening the assortment is important for our long-term strategy,” he says. “We are continuously looking for opportunities in high-value herbal products, phytochemicals, nutraceuticals and specialty ingredients. Our focus will remain on categories where we can achieve high-quality standards and deliver value.”
Over the next two to three years, the company plans to focus on portfolio expansion, export development, production and processing improvements, supply-chain strengthening, quality enhancement and innovation.
These priorities are intended to support more efficient operations while reinforcing the company’s position as a global B2B supplier of botanical and nutraceutical ingredients.
“Our priorities include expanding the portfolio, increasing export activities, improving production and processing, developing a robust supply chain and investing in quality and innovation,” Chandra says.
For Star Bio Pharma Global, the long-term ambition is clear: to be recognised as a trustworthy global supplier that combines botanical expertise with consistent quality, reliable documentation and responsive customer service. As the industry moves towards more standardised, traceable and application-focused ingredients, suppliers that can deliver across these areas will be best placed to capture the next phase of growth.
|
|
|
|
|
|
|
|
|
|